Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

Tandlægeholdingselskabet ID709 ApS Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading...   Loading...

1000.0 Bankruptcy Risk  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Bankruptcy risk for industry   1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 0.5% 0.5%   Bankruptcy risk   4.9% 7.5% 6.0% 5.6% 3.3% 4.3% 11.5% 11.5%   Credit score (0-100)   46 34 39 39 55 47 21 21   Credit rating   BBB BB BBB BBB BBB BBB BB BB   Credit limit (kDKK)   -0.0 -0.0 0.0 0.0 0.0 0.0 0.0 0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Gross profit   46.3 137 -29.2 -113 1.7 196 0.0 0.0   EBITDA   -844 -985 -202 -113 -2,501 -2,106 0.0 0.0   EBIT   -964 -1,132 -364 -284 -2,679 -2,284 0.0 0.0   Pre-tax profit (PTP)   210.1 98.9 1,386.3 2,430.7 178.4 122.8 0.0 0.0   Net earnings   173.5 64.7 1,054.3 1,865.9 169.6 98.8 0.0 0.0   Pre-tax profit without non-rec. items   210 98.9 1,386 2,431 178 123 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Tangible assets total   794 701 682 671 547 423 0.0 0.0   Shareholders equity total   223 180 1,124 1,990 1,609 1,538 4.3 4.3   Interest-bearing liabilities   579 938 290 854 2,405 2,198 225 225   Balance sheet total (assets)   1,438 1,274 1,853 3,953 4,430 4,242 229 229   Net Debt   579 938 290 854 2,084 2,198 225 225     See the entire balance sheet 1000.0 Volume  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Net sales growth   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   46.3 137 -29.2 -113 1.7 196 0.0 0.0   Gross profit growth   0.0% 196.2% 0.0% -286.0% 0.0% 11,224.0% -100.0% 0.0%   Employees   1 1 1 1 1 1 0 0   Employee growth %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% -100.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   1,438 1,274 1,853 3,953 4,430 4,242 229 229   Balance sheet change%   0.0% -11.4% 45.4% 113.4% 12.1% -4.2% -94.6% 0.0%   Added value   -843.9 -985.0 -202.4 -112.6 -2,507.8 -2,106.1 0.0 0.0   Added value %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   1,171 -294 -235 -235 -356 -356 -423 0   Net sales trend   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   EBIT trend   -1.0 -2.0 -3.0 -4.0 -5.0 -5.0 0.0 0.0   1000.0 Profitability  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A EBITDA %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   -2,081.5% -824.9% 1,248.2% 252.1% -154,507.0% -1,163.2% 0.0% 0.0%   Net Earnings %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   16.3% 12.4% 90.1% 86.5% 6.5% 6.1% 0.0% 0.0%   ROI %   25.9% 16.2% 106.7% 114.0% 7.7% 6.7% 0.0% 0.0%   ROE %   77.6% 32.1% 161.7% 119.9% 9.4% 6.3% 0.0% 0.0%   1000.0 Solidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Equity ratio %   15.5% 14.1% 60.7% 50.3% 36.3% 36.3% 1.9% 1.9%   Relative indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   -68.6% -95.2% -143.4% -758.5% -83.3% -104.3% 0.0% 0.0%   Gearing %   259.0% 520.3% 25.8% 42.9% 149.4% 142.9% 5,238.7% 5,238.7%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   8.4% 9.1% 3.7% 14.1% 5.7% 6.1% 0.0% 0.0%   1000.0 Liquidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Quick Ratio   0.1 0.0 0.0 0.0 1.1 1.0 0.0 0.0   Current Ratio   0.1 0.0 0.0 0.0 1.1 1.0 0.0 0.0   Cash and cash equivalent   0.0 0.0 0.0 0.0 320.7 0.0 0.0 0.0   1000.0 Capital use efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   -966.1 -1,050.6 -662.7 -1,883.0 161.3 -73.2 -112.3 -112.3   Net working capital %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   -844 -985 -202 -113 -2,508 -2,106 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   -844 -985 -202 -113 -2,501 -2,106 0 0   EBIT / employee   -964 -1,132 -364 -284 -2,679 -2,284 0 0   Net earnings / employee   173 65 1,054 1,866 170 99 0 0